Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | PF-07062119 |
| Trade Name | |
| Synonyms | PF07062119|PF 07062119 |
| Drug Descriptions |
PF-07062119 is a bispecific antibody that targets CD3 on T-cells and guanylyl cyclase C (GUCY2C) to induce a cytotoxic T-lymphocyte (PMID: 31996389). |
| DrugClasses | CD3 Antibody 119 |
| CAS Registry Number | NA |
| NCIT ID | C166258 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| PF-07062119 | PF-07062119 | 0 | 1 |
| PF-07062119 + unspecified PD-1 antibody | PF-07062119 unspecified PD-1 antibody | 0 | 1 |
| PF-07062119 + unspecified VEGF antibody | PF-07062119 unspecified VEGF antibody | 0 | 1 |